Literature DB >> 23572106

Automatic drusen quantification and risk assessment of age-related macular degeneration on color fundus images.

Mark J J P van Grinsven1, Yara T E Lechanteur, Johannes P H van de Ven, Bram van Ginneken, Carel B Hoyng, Thomas Theelen, Clara I Sánchez.   

Abstract

PURPOSE: To evaluate a machine learning algorithm that allows for computer-aided diagnosis (CAD) of nonadvanced age-related macular degeneration (AMD) by providing an accurate detection and quantification of drusen location, area, and size.
METHODS: Color fundus photographs of 407 eyes without AMD or with early to moderate AMD were randomly selected from a large European multicenter database. A machine learning system was developed to automatically detect and quantify drusen on each image. Based on detected drusen, the CAD software provided a risk assessment to develop advanced AMD. Evaluation of the CAD system was performed using annotations made by two blinded human graders.
RESULTS: Free-response receiver operating characteristics (FROC) analysis showed that the proposed system approaches the performance of human observers in detecting drusen. The estimated drusen area showed excellent agreement with both observers, with mean intraclass correlation coefficients (ICC) larger than 0.85. Maximum druse diameter agreement was lower, with a maximum ICC of 0.69, but comparable to the interobserver agreement (ICC = 0.79). For automatic AMD risk assessment, the system achieved areas under the receiver operating characteristic (ROC) curve of 0.948 and 0.954, reaching similar performance as human observers.
CONCLUSIONS: A machine learning system capable of separating high-risk from low-risk patients with nonadvanced AMD by providing accurate detection and quantification of drusen, was developed. The proposed method allows for quick and reliable diagnosis of AMD, opening the way for large dataset analysis within population studies and genotype-phenotype correlation analysis.

Entities:  

Mesh:

Year:  2013        PMID: 23572106     DOI: 10.1167/iovs.12-11449

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  12 in total

Review 1.  [Screening and management of retinal diseases using digital medicine].

Authors:  B S Gerendas; S M Waldstein; U Schmidt-Erfurth
Journal:  Ophthalmologe       Date:  2018-09       Impact factor: 1.059

Review 2.  [Epidemiology of age-related macular degeneration].

Authors:  C Brandl; K J Stark; M Wintergerst; M Heinemann; I M Heid; R P Finger
Journal:  Ophthalmologe       Date:  2016-09       Impact factor: 1.059

3.  Automatic differentiation of color fundus images containing drusen or exudates using a contextual spatial pyramid approach.

Authors:  Mark J J P van Grinsven; Thomas Theelen; Leonard Witkamp; Job van der Heijden; Johannes P H van de Ven; Carel B Hoyng; Bram van Ginneken; Clara I Sánchez
Journal:  Biomed Opt Express       Date:  2016-02-02       Impact factor: 3.732

4.  Automated drusen detection in dry age-related macular degeneration by multiple-depth, en face optical coherence tomography.

Authors:  Rui Zhao; Acner Camino; Jie Wang; Ahmed M Hagag; Yansha Lu; Steven T Bailey; Christina J Flaxel; Thomas S Hwang; David Huang; Dengwang Li; Yali Jia
Journal:  Biomed Opt Express       Date:  2017-10-17       Impact factor: 3.732

5.  Diving Deep into Deep Learning: An Update on Artificial Intelligence in Retina.

Authors:  Brian E Goldhagen; Hasenin Al-Khersan
Journal:  Curr Ophthalmol Rep       Date:  2020-06-07

6.  Automated Retinal Image Analysis for Evaluation of Focal Hyperpigmentary Changes in Intermediate Age-Related Macular Degeneration.

Authors:  Steffen Schmitz-Valckenberg; Arno P Göbel; Stefan C Saur; Julia S Steinberg; Sarah Thiele; Christian Wojek; Christoph Russmann; Frank G Holz
Journal:  Transl Vis Sci Technol       Date:  2016-03-04       Impact factor: 3.283

7.  Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention-MACUSTAR.

Authors:  Jan H Terheyden; Frank G Holz; Steffen Schmitz-Valckenberg; Anna Lüning; Matthias Schmid; Gary S Rubin; Hannah Dunbar; Adnan Tufail; David P Crabb; Alison Binns; Clara I Sánchez; Carel Hoyng; Philippe Margaron; Nadia Zakaria; Mary Durbin; Ulrich Luhmann; Parisa Zamiri; José Cunha-Vaz; Cecília Martinho; Sergio Leal; Robert P Finger
Journal:  Trials       Date:  2020-07-18       Impact factor: 2.279

8.  Genetic risk score has added value over initial clinical grading stage in predicting disease progression in age-related macular degeneration.

Authors:  Thomas J Heesterbeek; Eiko K de Jong; Ilhan E Acar; Joannes M M Groenewoud; Bart Liefers; Clara I Sánchez; Tunde Peto; Carel B Hoyng; Daniel Pauleikhoff; Hans W Hense; Anneke I den Hollander
Journal:  Sci Rep       Date:  2019-04-29       Impact factor: 4.379

9.  Automated detection of age-related macular degeneration in color fundus photography: a systematic review.

Authors:  Emma Pead; Roly Megaw; James Cameron; Alan Fleming; Baljean Dhillon; Emanuele Trucco; Thomas MacGillivray
Journal:  Surv Ophthalmol       Date:  2019-02-14       Impact factor: 6.048

10.  Genetic Association Analysis of Drusen Progression.

Authors:  Joshua D Hoffman; Mark J J P van Grinsven; Chun Li; Milam Brantley; Josephine McGrath; Anita Agarwal; William K Scott; Stephen G Schwartz; Jaclyn Kovach; Margaret Pericak-Vance; Clara I Sanchez; Jonathan L Haines
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-04-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.